September 25, 2020FALSE0000042888--12-25167,541,0972020Q3—29,657—29,65700000428882019-12-282020-09-25xbrli:shares00000428882020-10-14iso4217:USD00000428882020-06-272020-09-2500000428882019-06-292019-09-2700000428882018-12-292019-09-27iso4217:USDxbrli:shares00000428882020-09-2500000428882019-12-2700000428882018-12-2800000428882019-09-270000042888us-gaap:CommonStockMember2020-06-260000042888us-gaap:AdditionalPaidInCapitalMember2020-06-260000042888us-gaap:RetainedEarningsMember2020-06-260000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-2600000428882020-06-260000042888us-gaap:CommonStockMember2020-06-272020-09-250000042888us-gaap:AdditionalPaidInCapitalMember2020-06-272020-09-250000042888us-gaap:RetainedEarningsMember2020-06-272020-09-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-272020-09-250000042888us-gaap:CommonStockMember2020-09-250000042888us-gaap:AdditionalPaidInCapitalMember2020-09-250000042888us-gaap:RetainedEarningsMember2020-09-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-250000042888us-gaap:CommonStockMember2019-12-270000042888us-gaap:AdditionalPaidInCapitalMember2019-12-270000042888us-gaap:RetainedEarningsMember2019-12-270000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-270000042888us-gaap:CommonStockMember2019-12-282020-09-250000042888us-gaap:AdditionalPaidInCapitalMember2019-12-282020-09-250000042888us-gaap:RetainedEarningsMember2019-12-282020-09-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-282020-09-250000042888us-gaap:CommonStockMember2019-06-280000042888us-gaap:AdditionalPaidInCapitalMember2019-06-280000042888us-gaap:RetainedEarningsMember2019-06-280000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-2800000428882019-06-280000042888us-gaap:CommonStockMember2019-06-292019-09-270000042888us-gaap:AdditionalPaidInCapitalMember2019-06-292019-09-270000042888us-gaap:RetainedEarningsMember2019-06-292019-09-270000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-292019-09-270000042888us-gaap:CommonStockMember2019-09-270000042888us-gaap:AdditionalPaidInCapitalMember2019-09-270000042888us-gaap:RetainedEarningsMember2019-09-270000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-270000042888us-gaap:CommonStockMember2018-12-280000042888us-gaap:AdditionalPaidInCapitalMember2018-12-280000042888us-gaap:RetainedEarningsMember2018-12-280000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-280000042888us-gaap:CommonStockMember2018-12-292019-09-270000042888us-gaap:AdditionalPaidInCapitalMember2018-12-292019-09-270000042888us-gaap:RetainedEarningsMember2018-12-292019-09-270000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-292019-09-27ggg:segment0000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2020-06-272020-09-250000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2019-06-292019-09-270000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2019-12-282020-09-250000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2018-12-292019-09-270000042888us-gaap:OperatingSegmentsMemberggg:ProcessMember2020-06-272020-09-250000042888us-gaap:OperatingSegmentsMemberggg:ProcessMember2019-06-292019-09-270000042888us-gaap:OperatingSegmentsMemberggg:ProcessMember2019-12-282020-09-250000042888us-gaap:OperatingSegmentsMemberggg:ProcessMember2018-12-292019-09-270000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2020-06-272020-09-250000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2019-06-292019-09-270000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2019-12-282020-09-250000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2018-12-292019-09-270000042888us-gaap:CorporateNonSegmentMember2020-06-272020-09-250000042888us-gaap:CorporateNonSegmentMember2019-06-292019-09-270000042888us-gaap:CorporateNonSegmentMember2019-12-282020-09-250000042888us-gaap:CorporateNonSegmentMember2018-12-292019-09-270000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2020-09-250000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2019-12-270000042888us-gaap:OperatingSegmentsMemberggg:ProcessMember2020-09-250000042888us-gaap:OperatingSegmentsMemberggg:ProcessMember2019-12-270000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2020-09-250000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2019-12-270000042888us-gaap:CorporateNonSegmentMember2020-09-250000042888us-gaap:CorporateNonSegmentMember2019-12-270000042888country:US2020-06-272020-09-250000042888country:US2019-06-292019-09-270000042888country:US2019-12-282020-09-250000042888country:US2018-12-292019-09-270000042888us-gaap:NonUsMember2020-06-272020-09-250000042888us-gaap:NonUsMember2019-06-292019-09-270000042888us-gaap:NonUsMember2019-12-282020-09-250000042888us-gaap:NonUsMember2018-12-292019-09-270000042888country:US2020-09-250000042888country:US2019-12-270000042888us-gaap:NonUsMember2020-09-250000042888us-gaap:NonUsMember2019-12-270000042888us-gaap:EmployeeStockOptionMember2019-12-282020-09-250000042888us-gaap:EmployeeStockOptionMember2018-12-292019-09-27xbrli:pure0000042888us-gaap:EmployeeStockMember2019-12-282020-09-250000042888us-gaap:EmployeeStockMember2018-12-292019-09-270000042888us-gaap:PensionPlansDefinedBenefitMember2020-06-272020-09-250000042888us-gaap:PensionPlansDefinedBenefitMember2019-06-292019-09-270000042888us-gaap:PensionPlansDefinedBenefitMember2019-12-282020-09-250000042888us-gaap:PensionPlansDefinedBenefitMember2018-12-292019-09-270000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-06-272020-09-250000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-06-292019-09-270000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-282020-09-250000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2018-12-292019-09-270000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-260000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-06-260000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-272020-09-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-06-272020-09-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-09-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-270000042888us-gaap:AccumulatedTranslationAdjustmentMember2019-12-270000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-282020-09-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2019-12-282020-09-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-06-280000042888us-gaap:AccumulatedTranslationAdjustmentMember2019-06-280000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-06-292019-09-270000042888us-gaap:AccumulatedTranslationAdjustmentMember2019-06-292019-09-270000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-270000042888us-gaap:AccumulatedTranslationAdjustmentMember2019-09-270000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-280000042888us-gaap:AccumulatedTranslationAdjustmentMember2018-12-280000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-292019-09-270000042888us-gaap:AccumulatedTranslationAdjustmentMember2018-12-292019-09-270000042888us-gaap:CustomerRelationshipsMember2020-09-250000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2020-09-250000042888us-gaap:TrademarksAndTradeNamesMember2020-09-250000042888us-gaap:TradeNamesMember2020-09-250000042888us-gaap:CustomerRelationshipsMember2019-12-282020-09-250000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2019-12-282020-09-250000042888us-gaap:TrademarksAndTradeNamesMember2019-12-282020-09-250000042888us-gaap:TradeNamesMember2019-12-282020-09-250000042888us-gaap:CustomerRelationshipsMember2019-12-270000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2019-12-270000042888us-gaap:TrademarksAndTradeNamesMember2019-12-270000042888us-gaap:TradeNamesMember2019-12-270000042888us-gaap:CustomerRelationshipsMember2018-12-292019-12-270000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2018-12-292019-12-270000042888us-gaap:TrademarksAndTradeNamesMember2018-12-292019-12-270000042888us-gaap:TradeNamesMember2018-12-292019-12-2700000428882018-12-292019-12-270000042888ggg:IndustrialMember2019-12-270000042888ggg:ProcessMember2019-12-270000042888ggg:ContractorMember2019-12-270000042888ggg:IndustrialMember2019-12-282020-09-250000042888ggg:ProcessMember2019-12-282020-09-250000042888ggg:ContractorMember2019-12-282020-09-250000042888ggg:IndustrialMember2020-09-250000042888ggg:ProcessMember2020-09-250000042888ggg:ContractorMember2020-09-250000042888ggg:ShelfNotesMember2019-12-282020-09-250000042888ggg:ShelfNotesMember2020-09-250000042888ggg:CommittedFacilityMember2020-09-250000042888us-gaap:FairValueInputsLevel2Member2020-09-250000042888us-gaap:FairValueInputsLevel2Member2019-12-270000042888us-gaap:FairValueInputsLevel3Member2020-09-250000042888us-gaap:FairValueInputsLevel3Member2019-12-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
For the quarterly period ended September 25, 2020
☐Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from to
Commission File Number: 001-09249
GRACO INC.
(Exact name of registrant as specified in its charter)
Minnesota
41-0285640
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification Number)
88 - 11th Avenue N.E.
Minneapolis,
Minnesota
55413
(Address of principal executive offices)
(Zip Code)
(612)
623-6000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $1.00 per share
GGG
The New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☒
167,541,097 shares of the Registrant’s Common Stock, $1.00 par value, were outstanding as of October 14, 2020.
The consolidated balance sheet of Graco Inc. and Subsidiaries (the “Company”) as of September 25, 2020 and the related statements of earnings, comprehensive income and shareholders' equity for the three and nine months ended September 25, 2020 and September 27, 2019, and cash flows for the nine months ended September 25, 2020 and September 27, 2019 have been prepared by the Company and have not been audited.
In the opinion of management, these consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of the Company as of September 25, 2020, and the results of operations and cash flows for all periods presented.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. Therefore, these statements should be read in conjunction with the financial statements and notes thereto included in the Company’s 2019 Annual Report on Form 10-K.
The results of operations for interim periods are not necessarily indicative of results that will be realized for the full fiscal year.
2.Segment Information
The Company has three reportable segments: Industrial, Process and Contractor. Sales and operating earnings by segment were as follows (in thousands):
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
Three Months Ended
Nine Months Ended
September 25, 2020
September 27, 2019
September 25, 2020
September 27, 2019
Net earnings available to common shareholders
$
114,115
$
84,132
$
215,765
$
259,018
Weighted average shares outstanding for basic earnings per share
167,102
166,848
167,248
166,383
Dilutive effect of stock options computed using the treasury stock method and the average market price
4,551
4,929
4,367
5,178
Weighted average shares outstanding for diluted earnings per share
171,653
171,777
171,615
171,561
Basic earnings per share
$
0.68
$
0.50
$
1.29
$
1.56
Diluted earnings per share
$
0.66
$
0.49
$
1.26
$
1.51
Stock options to purchase 1,281,000 and 802,000 shares were not included in the September 25, 2020 and September 27, 2019 computations of diluted earnings per share, respectively, because they would have been anti-dilutive.
4.Share-Based Awards
Options on common shares granted and outstanding, as well as the weighted average exercise price, are shown below (in thousands, except exercise prices):
The Company recognized year-to-date share-based compensation of $21.4 million in 2020 and $23.2 million in 2019. As of September 25, 2020, there was $10.4 million of unrecognized compensation cost related to unvested options, expected to be recognized over a weighted average period of 2.5 years.
The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions and results:
Nine Months Ended
September 25, 2020
September 27, 2019
Expected life in years
7.5
7.5
Interest rate
1.5
%
2.6
%
Volatility
22.0
%
24.6
%
Dividend yield
1.3
%
1.4
%
Weighted average fair value per share
$
12.18
$
12.26
Under the Company’s Employee Stock Purchase Plan, the Company issued 400,000 shares in 2020 and 398,000 shares in 2019. The fair value of the employees’ purchase rights under this Plan was estimated on the date of grant. The benefit of the 15 percentdiscount from the lesser of the fair market value per common share on the first day and the last day of the plan year was added to the fair value of the employees’ purchase rights determined using the Black-Scholes option-pricing model with the following assumptions and results:
Nine Months Ended
September 25, 2020
September 27, 2019
Expected life in years
1.0
1.0
Interest rate
1.5
%
2.6
%
Volatility
21.9
%
22.7
%
Dividend yield
1.4
%
1.4
%
Weighted average fair value per share
$
11.55
$
11.36
5.Retirement Benefits
The components of net periodic benefit cost for retirement benefit plans were as follows (in thousands):
Changes in components of accumulated other comprehensive income (loss), net of tax were (in thousands):
Pension and Postretirement Medical
Cumulative Translation Adjustment
Total
Three Months Ended September 25, 2020
Balance, June 26, 2020
$
(109,695)
$
(53,987)
$
(163,682)
Other comprehensive income (loss) before reclassifications
—
30,966
30,966
Reclassified to pension cost and deferred tax
1,801
—
1,801
Balance, September 25, 2020
$
(107,894)
$
(23,021)
$
(130,915)
Nine Months Ended September 25, 2020
Balance, December 27, 2019
$
(113,721)
$
(56,066)
$
(169,787)
Other comprehensive income (loss) before reclassifications
—
33,045
33,045
Reclassified to pension cost and deferred tax
5,827
—
5,827
Balance, September 25, 2020
$
(107,894)
$
(23,021)
$
(130,915)
Three Months Ended September 27, 2019
Balance, June 28, 2019
$
(83,745)
$
(55,567)
$
(139,312)
Other comprehensive income (loss) before reclassifications
—
(6,396)
(6,396)
Reclassified to pension cost and deferred tax
1,763
—
1,763
Balance, September 27, 2019
$
(81,982)
$
(61,963)
$
(143,945)
Nine Months Ended September 27, 2019
Balance, December 28, 2018
$
(86,889)
$
(57,968)
$
(144,857)
Other comprehensive income (loss) before reclassifications
—
(3,995)
(3,995)
Reclassified to pension cost and deferred tax
4,907
—
4,907
Balance, September 27, 2019
$
(81,982)
$
(61,963)
$
(143,945)
In connection with the Company's sale of its U.K.-based valve business (“Alco”) in July of 2020, $24 million of unrealized foreign currency translation losses recorded in accumulated other comprehensive income were reclassified to net earnings for the three and nine months ended September 25, 2020. A loss reserve liability of $24 million related to the unrealized foreign currency losses was previously recognized in the second quarter of 2020 with the impairment of Alco. This reserve liability was eliminated upon sale and offsets the impact of the foreign currency translation reclassification on net earnings.
Amounts related to pension and postretirement medical adjustments are reclassified to non-service components of pension cost that are included within other non-operating expenses.
7.Inventories
Major components of inventories were as follows (in thousands):
September 25, 2020
December 27, 2019
Finished products and components
$
135,281
$
132,128
Products and components in various stages of completion
Components of other intangible assets were (dollars in thousands):
Finite Life
Indefinite Life
Customer Relationships
Patents and Proprietary Technology
Trademarks, Trade Names and Other
Trade Names
Total
As of September 25, 2020
Cost
$
186,073
$
25,313
$
1,000
$
61,920
$
274,306
Accumulated amortization
(90,280)
(12,380)
(358)
—
(103,018)
Foreign currency translation
(8,349)
(707)
—
(1,572)
(10,628)
Book value
$
87,444
$
12,226
$
642
$
60,348
$
160,660
Weighted average life in years
13
10
4
N/A
As of December 27, 2019
Cost
$
186,310
$
20,413
$
1,020
$
61,920
$
269,663
Accumulated amortization
(80,764)
(10,526)
(650)
—
(91,940)
Foreign currency translation
(10,412)
(885)
(73)
(3,730)
(15,100)
Book value
$
95,134
$
9,002
$
297
$
58,190
$
162,623
Weighted average life in years
13
10
4
N/A
Amortization of intangibles for the quarter was $4.2 million in 2020 and $3.9 million in 2019 and for the year to date was $12.5 million in 2020 and $11.6 million in 2019. Estimated annual amortization expense based on the current carrying amount of other intangible assets is as follows (in thousands):
2020
2021
2022
2023
2024
Thereafter
Estimated Amortization Expense
$
16,868
$
16,854
$
16,765
$
15,809
$
14,267
$
32,211
Changes in the carrying amount of goodwill for each reportable segment were (in thousands):
Components of other current liabilities were (in thousands):
September 25, 2020
December 27, 2019
Accrued self-insurance retentions
$
7,578
$
7,570
Accrued warranty and service liabilities
12,571
12,785
Accrued trade promotions
9,261
8,390
Payable for employee stock purchases
10,361
13,722
Customer advances and deferred revenue
52,206
33,138
Income taxes payable
6,331
8,706
Right of return refund liability
15,112
13,791
Operating lease liability, current
9,165
7,690
Other
32,695
37,145
Total
$
155,280
$
142,937
A liability is established for estimated future warranty and service claims that relate to current and prior period sales. The Company estimates warranty costs based on historical claim experience and other factors including evaluating specific product warranty issues. Following is a summary of activity in accrued warranty and service liabilities (in thousands):
Balance, December 27, 2019
$
12,785
Assumed in business acquisition
155
Charged to expense
5,495
Margin on parts sales reversed
2,000
Reductions for claims settled
(7,864)
Balance, September 25, 2020
$
12,571
Deferred Revenue
Revenue is deferred when cash payments are received or due in advance of performance, including amounts which are refundable. This is also the case for services associated with certain product sales. The balance in the deferred revenue and customer advances was $52.2 million as of September 25, 2020 and $33.1 million as of December 27, 2019. Net sales for the year to date included $25.9 million in 2020 and $34.9 million in 2019 that related to deferred revenue as of the beginning of each period.
10.Debt
On January 29, 2020, the Company entered into a master note agreement with a sole lender that expires on January 29, 2023. The note agreement sets forth certain terms on which the Company may issue, and affiliates of the lender may purchase, up to $200 million of the Company’s senior notes. Interest on the senior notes will be determined at the time of issuance, at a fixed or LIBOR-based floating rate at the option of the Company, provided that the maximum aggregate principal amount of notes bearing interest at a floating rate may not exceed $100 million. Fixed rate notes issued under the agreement will mature no longer than 12 years from date of issuance and variable rate notes will mature no longer than 10 years from issuance. Under terms of the note agreement, the Company is required to maintain certain financial ratios as to cash flow leverage and interest coverage similar to the requirements of its other debt agreements. There were no senior notes issued under the note agreement as of September 25, 2020.
In March 2020, the Company borrowed $250 million under its $500 million revolving credit facility in order to increase its cash position and preserve financial flexibility. The proceeds from the advance are available to be used for working capital, general corporate or other purposes. In August 2020, the Company made a payment of $125 million against the revolving credit facility.
Assets and liabilities measured at fair value on a recurring basis and fair value measurement level were as follows (in thousands):
Level
September 25, 2020
December 27, 2019
Assets
Cash surrender value of life insurance
2
$
17,273
$
17,702
Forward exchange contracts
2
388
—
Total assets at fair value
$
17,661
$
17,702
Liabilities
Contingent consideration
3
$
9,128
$
9,072
Deferred compensation
2
4,855
4,719
Forward exchange contracts
2
—
87
Total liabilities at fair value
$
13,983
$
13,878
Contracts insuring the lives of certain employees who are eligible to participate in certain non-qualified pension and deferred compensation plans are held in trust. Cash surrender value of the contracts is based on performance measurement funds that shadow the deferral investment allocations made by participants in certain deferred compensation plans. Changes in cash surrender value are recorded in other non-operating expense. The deferred compensation liability balances are valued based on amounts allocated by participants to the underlying performance measurement funds.
Contingent consideration liability represents the estimated value (using a probability-weighted expected return approach) of future payments to be made to previous owners of certain acquired businesses based on future revenues.
Long-term notes payable with fixed interest rates had a carrying amount of $150 million and estimated fair value of $165 million as of both September 25, 2020 and December 27, 2019. The fair value of variable rate borrowings approximates carrying value. The Company uses significant other observable inputs to estimate fair value (level 2 of the fair value hierarchy) based on the present value of future cash flows and rates that would be available for issuance of debt with similar terms and remaining maturities.
12Recent Accounting Pronouncements
Adoption of New Accounting Standard
In June 2016, the Financial Accounting Standards Board (FASB) issued a final standard on accounting for credit losses. The new standard is effective for the Company in fiscal 2020 and requires a change in credit loss calculations using the expected loss method. There was no significant impact on earnings or financial condition from the adoption of the new standard.
Accounting Policy
Receivables reflected in the financial statements represent the net amount expected to be collected. An allowance for credit losses is established based on expected losses. Expected losses are estimated by reviewing individual accounts, considering aging, financial condition of the debtor, recent payment history, current and forecast economic conditions and other relevant factors. The Company evaluates the adequacy of the worldwide allowance amount quarterly, considering individual account reviews, historical write-offs, current sales levels and expected economic factors.
Accounts Receivable
Accounts receivable includes trade receivables of $299 million and other receivables of $15 million as of September 25, 2020 and $256 million and $11 million, respectively, as of December 27, 2019.
Following is a summary of activity in the allowance for credit losses (in thousands):
Three Months Ended
Nine Months Ended
September 25, 2020
September 27, 2019
September 25, 2020
September 27, 2019
Balance, beginning
$
5,159
$
4,315
$
4,828
$
4,771
Additions (reversals) charged to costs and expenses
(293)
209
338
431
Deductions from reserves (1)
(956)
(109)
(1,247)
(799)
Other additions (deductions) (2)
115
(64)
106
(52)
Balance, ending
$
4,025
$
4,351
$
4,025
$
4,351
(1) Represents amounts determined to be uncollectible and charged against reserves, net of collections on accounts previously charged against reserves.
(2) Includes amounts assumed or established in connection with acquisitions and effects of foreign currency translation.
The Company supplies technology and expertise for the management of fluids and coatings in both industrial and commercial applications. It designs, manufactures and markets systems and equipment to move, measure, control, dispense and spray fluid and coating materials. Management classifies the Company’s business into three reportable segments: Industrial, Process and Contractor. Key strategies include developing and marketing new products, leveraging products and technologies into additional, growing end-user markets, expanding distribution globally and completing strategic acquisitions that provide additional channel and technologies.
The following Management’s Discussion and Analysis reviews significant factors affecting the Company’s results of operations and financial condition. This discussion should be read in conjunction with the financial statements and the accompanying notes to the financial statements.
Consolidated Results
A summary of financial results follows (in millions except per share amounts):
Three Months Ended
Nine Months Ended
Sep 25, 2020
Sep 27, 2019
% Change
Sep 25, 2020
Sep 27, 2019
% Change
Net Sales
$
439.3
$
400.6
10
%
$
1,179.8
$
1,233.8
(4)
%
Operating Earnings
125.0
103.4
21
%
259.6
320.3
(19)
%
Net Earnings
114.1
84.1
36
%
215.8
259.0
(17)
%
Net Earnings, adjusted (1)
101.8
77.4
32
%
229.2
243.4
(6)
%
Diluted Net Earnings per Common Share
$
0.66
$
0.49
35
%
$
1.26
$
1.51
(17)
%
Diluted Net Earnings per Common Share, adjusted (1)
$
0.59
$
0.45
31
%
$
1.34
$
1.42
(6)
%
(1) See below for a reconciliation of adjusted non-GAAP financial measures to GAAP.
Double-digit sales growth in the Contractor segment offset declines in other segments for the quarter. Sales declined in other segments for the year to date, although the rate of decline slowed in the third quarter. Changes in currency translation rates increased worldwide sales by approximately $4 million for the quarter and decreased sales by approximately $5 million year to date. Sales from acquired operations contributed approximately $4 million (1 percentage point) to the third quarter and $16 million (1 percentage point) year to date.
Gross margin rates for the quarter were up slightly from the comparable period last year as price realization and lower product costs offset the impacts of product and channel mix. Total operating expenses for the quarter were comparable to the prior year.
Excluding the impact of impairment charges, excess tax benefits related to stock option exercises and certain tax provision adjustments presents a more consistent basis for comparison of financial results. A calculation of the non-GAAP measurements of adjusted operating earnings, earnings before income taxes, income taxes, effective income tax rates, net earnings and diluted earnings per share follows (in millions except per share amounts):
The following table presents an overview of components of net earnings as a percentage of net sales:
Three Months Ended
Nine Months Ended
September 25, 2020
September 27, 2019
September 25, 2020
September 27, 2019
Net Sales
100.0
%
100.0
%
100.0
%
100.0
%
Cost of products sold
47.9
48.2
48.3
47.3
Gross Profit
52.1
51.8
51.7
52.7
Product development
4.0
4.3
4.5
4.1
Selling, marketing and distribution
12.3
13.9
13.7
14.3
General and administrative
7.3
7.9
8.7
8.3
Impairment
0.1
—
3.0
—
Operating Earnings
28.5
25.8
22.0
26.0
Interest expense
0.7
0.9
0.7
0.9
Other expense (income), net
0.2
0.7
0.5
0.4
Earnings Before Income Taxes
27.5
24.2
20.8
24.7
Income taxes
1.6
3.2
2.6
3.8
Net Earnings
26.0
%
21.0
%
18.3
%
21.0
%
Net Sales
The following table presents net sales by geographic region (in millions):
Three Months Ended
Nine Months Ended
September 25, 2020
September 27, 2019
September 25, 2020
September 27, 2019
Americas(1)
$
277.1
$
243.0
$
729.6
$
728.9
EMEA(2)
93.0
94.0
251.9
294.5
Asia Pacific
69.2
63.6
198.3
210.4
Consolidated
$
439.3
$
400.6
$
1,179.8
$
1,233.8
(1) North, South and Central America, including the United States
(2)Europe, Middle East and Africa
The following table presents the components of net sales change by geographic region:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions
Currency
Total
Americas
13%
1%
0%
14%
0%
1%
(1)%
0%
EMEA
(5)%
0%
4%
(1)%
(15)%
1%
0%
(14)%
Asia Pacific
5%
2%
2%
9%
(8)%
3%
(1)%
(6)%
Consolidated
8%
1%
1%
10%
(5)%
1%
0%
(4)%
Gross Profit
The third quarter gross margin rate was up slightly from the comparable period last year as price realization, lower product costs and favorable currency translation offset the impacts of product and channel mix. For the year to date, the gross margin rate declined by 1 percentage point. Price realization was not enough to offset the impacts of unfavorable product and channel mix (lower high-margin Industrial segment sales combined with growth in lower-margin Contractor segment sales).
Operating expenses for the quarter and year to date included $0.3 million and $35 million, respectively, of non-cash impairment charges related to the third quarter sale of the Company's U.K.-based valve business (“Alco”). The impact of the impairment on net earnings for the year to date was $34 million or $0.20 per diluted share. Total operating expenses for the quarter were comparable to the prior year period and down $15 million (4 percent) year to date. Reductions in volume and earnings-based expenses offset increases in product development spending for the quarter and more than offset increases in product development spending for the year to date.
Other Expense
Other non-operating expenses decreased $2 million for the quarter and increased $1 million year to date mostly due to market valuation fluctuations on investments held to fund certain retirement benefits liabilities.
Income Taxes
The effective income tax rate for the quarter was 6 percent, down 7 percentage points from the comparable period last year, primarily due to additional foreign tax benefits and an increase in excess tax benefits related to stock option exercises. The effective income tax rate for the year to date was 12 percent, down 3 percentage points from the comparable period last year. The year to date decrease was due primarily to additional foreign tax benefits and excess tax benefits related to stock option exercises partially offset by non-deductible impairment charges.
Economic Uncertainty
The ongoing COVID-19 pandemic and related governmental and business responses continue to have an adverse effect on our operations, supply chains, distribution channels, and end-user customers. Incoming order rates for our Industrial and Process segments have not recovered to pre-pandemic levels. While our Contractor segment has seen growth in order rates, there is uncertainty with respect to the duration and level at which the activity will continue.
We manufacture and provide essential products and services to a variety of critical infrastructure customers. We have remained operational during the pandemic and we intend to continue providing our products and services to our customers. Our commercial teams are focused on customer service, maintaining end-user customer contact and providing support to our distributors. Our engineering teams continue to develop and launch new products.
As a result of the pandemic and various governmental orders, a significant number of our employees are working from home, and we altered our manufacturing operations to allow for appropriate social distancing, hygiene, cleaning and disinfecting. In our supply chain, we have experienced isolated instances of suppliers temporarily closing their operations, delaying order fulfillment or limiting their production, and we are utilizing alternative supply arrangements as needed. We have also experienced isolated instances of distributors reducing or closing their operations, impacting the ability of some of our end-user customers to procure our products through our traditional distribution channels. Some of our end-user customers are deferring capital equipment purchases, and have eliminated in-person sales meetings. In addition, trade shows, industry events and product demonstrations have been cancelled or postponed. As a result, our selling activities and our ability to convert those activities into sales have been and we expect will continue to be adversely impacted. We will continue to manage our working capital, such as receivables and inventory, to align with customer needs and changes in demand for our products and services.
The timing and extent of the economic recovery from the pandemic in our major geographies is still uncertain and we cannot predict the magnitude of the impact to the results of our operations or financial position. We do not expect the pandemic to have a significant effect on our liquidity as operating cash flows and available liquidity are sufficient to support operations at current order rates (see Liquidity and Capital Resources below).
Segment Results
Certain measurements of segment operations compared to last year are summarized below:
Industrial Segment
The following table presents net sales and operating earnings as a percentage of sales for the Industrial segment
The following table presents the components of net sales change by geographic region for the Industrial segment:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions
Currency
Total
Americas
(1)%
0%
(1)%
(2)%
(12)%
0%
(1)%
(13)%
EMEA
(9)%
0%
4%
(5)%
(22)%
0%
0%
(22)%
Asia Pacific
3%
0%
1%
4%
(12)%
0%
(1)%
(13)%
Segment Total
(3)%
0%
2%
(1)%
(15)%
0%
(1)%
(16)%
Industrial segment sales declined for the quarter and year to date as most geographies continued to be impacted by government actions that reduced economic activity. Operating earnings as a percentage of sales increased 2 percentage points for the quarter driven by price realization, lower product costs and operating expense leverage. While gross margin rates in this segment remained relatively strong year to date, decreases in operating expenses did not keep pace with the drop in sales volume, driving operating earnings as a percentage of sales down 2 percentage points.
Process Segment
The following table presents net sales and operating earnings as a percentage of sales for the Process segment
(dollars in millions):
Three Months Ended
Nine Months Ended
September 25, 2020
September 27, 2019
September 25, 2020
September 27, 2019
Net Sales
Americas
$
52.2
$
55.2
$
153.2
$
167.5
EMEA
11.5
15.4
40.5
45.5
Asia Pacific
15.1
13.5
48.9
43.1
Total
$
78.8
$
84.1
$
242.6
$
256.1
Operating earnings as a percentage of net sales
21
%
22
%
19
%
22
%
The following table presents the components of net sales change by geographic region for the Process segment:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions
Currency
Total
Americas
(10)%
4%
0%
(6)%
(12)%
4%
(1)%
(9)%
EMEA
(29)%
2%
2%
(25)%
(18)%
7%
0%
(11)%
Asia Pacific
2%
9%
2%
13%
0%
15%
(1)%
14%
Segment Total
(12)%
5%
1%
(6)%
(11)%
6%
0%
(5)%
Sales from acquired operations in the Process segment were unable to offset volume declines in organic businesses. Operating earnings as a percentage of sales decreased 1 percentage point for the quarter and 3 percentage points year
to date driven by lower volume and unfavorable product and channel mix, partially offset by the impact of divested operations.
Contractor Segment
The following table presents net sales and operating earnings as a percentage of sales for the Contractor segment
(dollars in millions):
Three Months Ended
Nine Months Ended
September 25, 2020
September 27, 2019
September 25, 2020
September 27, 2019
Net Sales
Americas
$
148.7
$
110.2
$
367.4
$
322.2
EMEA
28.9
23.3
77.7
76.5
Asia Pacific
10.1
8.0
27.3
26.4
Total
$
187.7
$
141.5
$
472.4
$
425.1
Operating earnings as a percentage of net sales
29
%
24
%
26
%
24
%
The following table presents the components of net sales change by geographic region for the Contractor segment:
Three Months
Nine Months
Volume and Price
Acquisitions
Currency
Total
Volume and Price
Acquisitions
Currency
Total
Americas
35%
0%
0%
35%
14%
0%
0%
14%
EMEA
19%
0%
5%
24%
2%
0%
(1)%
1%
Asia Pacific
24%
0%
2%
26%
6%
0%
(3)%
3%
Segment Total
32%
0%
1%
33%
11%
0%
0%
11%
Contractor segment sales increased in all geographies for the quarter and year to date. Favorable response to new product offerings and continued strength in construction and home improvement markets drove the increase. Increased volume contributed to the increase in operating earnings as a percentage of sales for the quarter and year to date.
Liquidity and Capital Resources
Net cash provided by operating activities of $263 million decreased $36 million compared to the first nine months of last year. Changes in accounts receivable and inventories drove the decrease, and reflect growth in business activity of the Contractor segment in the third quarter of 2020. Purchases of Company common stock totaling $102 million in 2020 were partially offset by net proceeds from shares issued totaling $56 million. Other significant uses of cash included dividend payments of $88 million, property, plant and equipment additions of $46 million and business acquisitions of $28 million. The Company may make additional opportunistic share purchases going forward.
In March 2020, the Company borrowed $250 million under its $500 million revolving credit facility in order to increase its cash position and preserve financial flexibility. The proceeds from the advance are available to be used for working capital, general corporate or other purposes. In August 2020, the Company made a payment of $125 million against the revolving credit facility.
Significant uses of cash in 2019 included cash dividends of $80 million, property, plant and equipment additions of $102 million, prepayment of $75 million of private placement debt that was due in 2020, and business acquisitions totaling $19 million. Proceeds from shares issued in the first half of 2019 totaled $36 million, partially offset by $5 million of payments for shares repurchased.
At September 25, 2020, the Company had various lines of credit totaling $596 million, of which $429 million was unused. In addition to its lines of credit, under the terms of a master note agreement with a sole lender expiring in January 2023, the Company may issue up to $200 million of senior notes. Interest on the notes will be determined at the time of issuance, at a fixed or LIBOR-based floating rate at the option of the Company, provided that the maximum aggregate principal amount of notes bearing interest at a floating rate may not exceed $100 million. Fixed rate notes issued under
the agreement will mature no longer than 12 years from date of issuance and variable rate notes will mature no longer than 10 years from date of issuance.
Cash balances and unused financing sources are expected to provide the Company with the flexibility to meet its liquidity needs in 2020, including its capital expenditure plan, planned dividends, share repurchases, acquisitions and operating requirements.
Outlook
Weak global economic conditions continued to affect most of our business in the third quarter. We remain committed to our long-term strategy as our initiatives for 2021 and beyond have continued as usual. We will use this difficult period to strengthen our competitive position, expand our product offering, build our global channel and enter new market spaces. These initiatives may put pressure on our short-term financial results, but will position us to capitalize when market conditions normalize. We also recognize that the timing and shape of a recovery is highly uncertain. We will remain agile and have contingency plans in place to appropriately respond to conditions as they unfold.
The Company desires to take advantage of the “safe harbor” provisions regarding forward-looking statements of the Private Securities Litigation Reform Act of 1995 and is filing this Cautionary Statement in order to do so. From time to time various forms filed by our Company with the Securities and Exchange Commission, including our Form 10-K, Form 10-Qs and Form 8-Ks, and other disclosures, including our 2019 Overview report, press releases, earnings releases, analyst briefings, conference calls and other written documents or oral statements released by our Company, may contain forward-looking statements. Forward-looking statements generally use words such as “expect,” “foresee,” “anticipate,” “believe,” “project,” “should,” “estimate,” “will,” and similar expressions, and reflect our Company’s expectations concerning the future. All forecasts and projections are forward-looking statements. Forward-looking statements are based upon currently available information, but various risks and uncertainties may cause our Company’s actual results to differ materially from those expressed in these statements. The Company undertakes no obligation to update these statements in light of new information or future events.
Future results could differ materially from those expressed due to the impact of changes in various factors. These risk factors include, but are not limited to: the impact of the COVID-19 pandemic on our business; economic conditions in the United States and other major world economies; our Company’s growth strategies, which include making acquisitions, investing in new products, expanding geographically and targeting new industries; changes in currency translation rates; the ability to meet our customers’ needs and changes in product demand; supply interruptions or delays; security breaches; new entrants who copy our products or infringe on our intellectual property; risks incident to conducting business internationally; catastrophic events; changes in laws and regulations; compliance with anti-corruption and trade laws; changes in tax rates or the adoption of new tax legislation; the possibility of asset impairments if acquired businesses do not meet performance expectations; political instability; results of and costs associated with litigation, administrative proceedings and regulatory reviews incident to our business; our ability to attract, develop and retain qualified personnel; the possibility of decline in purchases from a few large customers of the Contractor segment; and variations in activity in the construction, automotive, mining and oil and natural gas industries. Please refer to Item 1A of our Annual Report on Form 10-K for fiscal year 2019 and Item 1A of this Form 10-Q for a more comprehensive discussion of these and other risk factors. These reports are available on the Company’s website at www.graco.com and the Securities and Exchange Commission’s website at www.sec.gov. Shareholders, potential investors and other readers are urged to consider these factors in evaluating forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.
Investors should realize that factors other than those identified above and in Item 1A might prove important to the Company’s future results. It is not possible for management to identify each and every factor that may have an impact on the Company’s operations in the future as new factors can develop from time to time.
Item 3.Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes related to market risk from the disclosures made in the Company’s 2019 Annual Report on Form 10-K.
As of the end of the fiscal quarter covered by this report, the Company carried out an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures. This evaluation was done under the supervision and with the participation of the Company’s President and Chief Executive Officer and the Chief Financial Officer and Treasurer. Based upon that evaluation, the Company's President and Chief Executive Officer and the Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective.
Changes in internal controls
During the quarter, there was no change in the Company’s internal control over financial reporting that has materially affected or is reasonably likely to materially affect the Company’s internal control over financial reporting.
PART IIOTHER INFORMATION
Item 1A.Risk Factors
Except as noted below, there have been no material changes to the Company’s risk factors from those disclosed in the Company’s 2019 Annual Report on Form 10-K.
Coronavirus Disease 2019 (COVID-19) - The COVID-19 pandemic, the governmental responses to the pandemic, and the resulting decline in global economic activity have adversely affected our business and results of operations, and could have a material and adverse effect on our business, results of operations and financial condition in the future.
In response to the COVID-19 pandemic, federal, provincial, state, county and local governments and public health organizations and authorities around the world implemented a variety of measures intended to control the spread of the virus, including quarantines, “shelter-in-place,” “stay-at-home” and similar orders, travel restrictions, school closures, business curtailments and closures, social distancing and hygiene requirements, and other measures. While there has been a loosening of some of these measures in certain areas, the ongoing pandemic and outbreaks of COVID-19 in various areas has resulted in, and may continue to result in, reinstating these measures or implementing new or additional measures in certain areas.
We manufacture and provide essential products and services to a variety of critical infrastructure customers around the globe. We have remained operational during the pandemic, and we intend to continue providing our products and services to our customers. However, the COVID-19 pandemic and related governmental and business responses have had, and will likely continue to have, an adverse effect on our operations, supply chains, distribution channels, and end-user customers. For example, as a result of the pandemic and various governmental orders, a significant number of our employees are working from home, and we substantially altered our manufacturing operations to allow for appropriate social distancing and hygiene, which could lead to decreased efficiency and productivity in our workforce and our operations. In our supply chain, we have experienced isolated instances of suppliers temporarily closing their operations, delaying order fulfillment or limiting their production due to the pandemic, and we are utilizing alternative supply arrangements where appropriate or necessary, which may lead to increased costs, delays, and difficulties sourcing certain products. Similarly, we have experienced isolated instances of distributors reducing or closing their operations, impacting the ability of some of our end-user customers to procure our products through our traditional distribution channels. Someof our end-user customers are deferring capital equipment purchases and have eliminated in-person sales meetings. In addition, trade shows, industry events and product demonstrations have been cancelled and are continuing to be cancelled or postponed. As a result, our selling activities and our ability to convert those activities into actual sales have been and will continue to be adversely impacted. In addition, management is focused on mitigating the effects of the COVID-19 pandemic, which has required and will continue to require a large investment of time, energy, resources and focus.
The extent to which the COVID-19 pandemic impacts us will depend on numerous evolving factors and future developments that are uncertain and that we are not able to predict, including: the severity of the virus; the duration and scope of the pandemic; whether there are additional waves of the pandemic; whether there are continued increases or spikes in COVID-19 cases in the areas in which we or our suppliers, distributors or end-user customers operate; governmental, business, individual and other actions taken in response to the pandemic; the effect on our suppliers and distributors, and disruptions to the global supply chain; the impact on economic activity; the extent and duration of the impact on consumer and business confidence and spending; the effect on our end-user customers and their demand and
buying patterns for our products and services; the effect of any closures or other changes in operations of our and our suppliers’, distributors’ and end-user customers’ facilities; the health of and the effect on our employees and our ability to meet staffing needs in our manufacturing and distribution facilities and other critical functions, particularly if a significant number of employees become ill, are quarantined as a result of exposure, or are reluctant to show up for work; our ability to sell our products and services and provide product support, including as a result of travel restrictions, work from home requirements and arrangements, and other restrictions or changes in behavior or preferences for interactions; the effect on employee healthcare costs under our self-insurance programs; restrictions or disruptions to transportation, including reduced availability of ground, sea or air transport; the ability of our distributors and end-user customers to pay for our products and services; the potential effects on our internal controls, including those over financial reporting, as a result of changes in working arrangements that are applicable to our employees and business partners; and the effect on our ability to access capital on favorable terms and continue to meet our liquidity needs, all of which are highly uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of the economic recession that has occurred and any economic recession that may occur in the future. The COVID-19 pandemic could also exacerbate or trigger other risks discussed in our 2019 Annual Report on Form 10-K, any of which could have a material and adverse effect on our business, results of operations and financial condition.
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
On April 24, 2015, the Board of Directors authorized the Company to purchase up to 18,000,000 shares of its outstanding common stock, primarily through open-market transactions. There were approximately 3.3 million shares remaining under the authorization on December 7, 2018, when the board of Directors authorized the purchase of up to an additional 18 million shares. The authorizations are for an indefinite period of time or until terminated by the Board.
In addition to shares purchased under the Board authorizations, the Company purchases shares of common stock held by employees who wish to tender owned shares to satisfy the exercise price or tax due upon exercise of options or vesting of restricted stock.
Information on issuer purchases of equity securities follows:
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (at end of period)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
